Rong Zhou - 13 Jun 2023 Form 4 Insider Report for Amphastar Pharmaceuticals, Inc. (AMPH)

Role
EVP, Production Center
Signature
/s/ Eva Wen, by power of attorney
Issuer symbol
AMPH
Transactions as of
13 Jun 2023
Net transactions value
-$169,200
Form type
4
Filing time
14 Jun 2023, 17:36:12 UTC
Previous filing
19 May 2023
Next filing
20 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMPH Common Stock Options Exercise $72,000 +5,000 +5.7% $14.40 93,313 13 Jun 2023 Direct F1
transaction AMPH Common Stock Sale $241,200 -5,000 -5.4% $48.24 88,313 13 Jun 2023 Direct
holding AMPH Common Stock 99,668 13 Jun 2023 See footnote F2
holding AMPH Common Stock 5,000 13 Jun 2023 See footnote F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMPH Employee Stock Option (right to buy) Options Exercise $0 -5,000 -22% $0.000000 17,891 13 Jun 2023 Common Stock 5,000 $14.40 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 715 shares acquired under the Issuer's 2014 Employee Stock Purchase Plan on May 31, 2023.
F2 The shares are held of record by the Zhou Family Trust for which the reporting person serves as a trustee.
F3 The shares are held of record by the reporting person's spouse.
F4 Shares subject to the option are fully vested and immediately exercisable.